Dr. Hanlon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3580 Joseph Siewick Dr
403
Fairfax, VA 22033Phone+1 703-391-4395Fax+1 703-391-4394
Education & Training
Duke University HospitalHematology/Oncology, 2018 - 2021- Duke University HospitalResidency, Internal Medicine, 2015 - 2018
Medical University of South CarolinaClass of 2014
Certifications & Licensure
VA State Medical License 2021 - 2026
NC State Medical License 2014 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 29 citationsCaplacizumab in adult patients with acquired thrombotic thrombocytopenic purpura.Ashley Hanlon, Ara Metjian
Therapeutic Advances in Hematology. 2020-02-07 - 29 citationsManaging toxicities of phosphatidylinositol-3-kinase (PI3K) inhibitorsAshley Hanlon, Danielle M. Brander
Hematology. American Society of Hematology. Education Program. 2020-12-04 - Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia at first relapse.Rachel Hu, Wei Wei, Agrima Mian, Kristen Gonter-Aubin, Charlene Kabel
European Journal of Haematology. 2022-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
